Back to Search
SASHA RISTIC, MD
MD
Orthopaedic Hand Surgery Physician
NPI: 1669499109IndividualAccepts Medicare
Specialties, Licenses & Credentials
Orthopaedic Hand Surgery PhysicianPrimary
Orthopaedic Surgery — Hand Surgery
Code: 207XS0106X
213696(NY)
Orthopaedic Surgery Physician
Orthopaedic Surgery
Code: 207X00000X
213696(NY)
Education
COLUMBIA UNIVERSITY COLLEGE OF PHYSICIANS AND SURGEONS
Class of 1993
Research & Publications (20)
Effects of rapid-acting insulin analogs on overall glycemic control in type 1 and type 2 diabetes mellitus.
PMID 12725708·Diabetes Technol Ther·2003
4-observational
Acceptability of a reusable insulin pen, HumaPen Ergo, by patients with type 1 and type 2 diabetes.
PMID 12017212·Curr Med Res Opin·2002
4-observational
The assessment and treatment of nerve dysfunction after trauma around the elbow.
PMID 10660708·Clin Orthop Relat Res·2000
6-review
Molecular response to imatinib in patient with Ph negative p190 BCR-ABL transcript positive chronic myeloid leukemia with cyclic leukocytosis.
PMID 19091403·Leuk Res·2009
5-case
Molecular characteristics and prognostic significance of Bcl-2/IgH gene rearrangement in Serbian follicular lymphoma patients.
PMID 18665753·Neoplasma·2008
8-other
Survey of attitudes towards curriculum reforms among medical teachers in different socio-economic and cultural environments.
PMID 18236281·Med Teach·2007
8-other
Nateglinide or gliclazide in combination with metformin for treatment of patients with type 2 diabetes mellitus inadequately controlled on maximum doses of metformin alone: 1-year trial results.
PMID 17587393·Diabetes Obes Metab·2007
4-observational
Predictive value of prognostic indices in patients with follicular lymphomas.
PMID 17303912·Med Oncol·2006
4-observational
Vildagliptin: a novel DPP-4 inhibitor with pancreatic islet enhancement activity for treatment of patients with type 2 diabetes.
PMID 16969429·Drugs Today (Barc)·2006
6-review
Comparison of nateglinide and gliclazide in combination with metformin, for treatment of patients with Type 2 diabetes mellitus inadequately controlled on maximum doses of metformin alone.
PMID 16842480·Diabet Med·2006
4-observational
Improved glycaemic control with dipeptidyl peptidase-4 inhibition in patients with type 2 diabetes: vildagliptin (LAF237) dose response.
PMID 16219012·Diabetes Obes Metab·2005
2-rct
Osseous sarcoidosis of the hand: pathologic analysis and review of the literature.
PMID 16039384·J Hand Surg Am·2005
5-case
Conversion of azathioprine to mycophenolate mofetil and chronic graft failure progression.
PMID 15848517·Transplant Proc·2005
3-trial
Metabolic control in patients with type 2 diabetes using Humalog Mix50 injected three times daily: crossover comparison with human insulin 30/70.
PMID 15057674·Horm Metab Res·2004
3-trial
HPLC determination of tiazofurin in the rat brain.
PMID 14623613·J Pharm Biomed Anal·2003
7-preclinical
Simultaneous LC determination of tiazofurin, its acetyl and benzoyl esters and their active metabolite thiazole-4-carboxamide adenine dinucleotide in biological samples.
PMID 12408890·J Pharm Biomed Anal·2002
7-preclinical
Synthesis of some new antianemics I. Iron pullulan complexes of pharmaceutical interest.
PMID 11933841·Pharmazie·2002
8-other
Busulfan-induced loss of Ph chromosome in chronic myeloid leukemia.
PMID 11917947·Med Oncol·2001
5-case
Intramuscular injection of insulin lispro or soluble human insulin: pharmacokinetics and glucodynamics in Type 2 diabetes.
PMID 11553186·Diabet Med·2001
3-trial
Treatment of type 1 diabetes with insulin lispro during Ramadan.
PMID 11547222·Diabetes Metab·2001
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1910 SOUTH RD
POUGHKEEPSIE, NY 12601 - Phone
- (845) 454-0120
Quick Facts
- NPI
- 1669499109
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 33
- Publications
- 20
Are you this provider?
Claim Your Profile